Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients
Open accessAbstract
BACKGROUND: Ambulatory outpatients (n = 150) with a history of paroxysmal supraventricular arrhythmia were studied to establish the characteristics of the first recurrence of symptomatic tachycardia (time to first recurrence, heart rate during tachycardia, and observed rhythm that was regular versus irregular) when no antiarrhythmic drug was being taken. Baseline variables were examined to assess their impact on time to first recurrence: index arrhythmia (paroxysmal atrial fibrillation [n = 37] versus paroxysmal supraventricular tachycardia [n = 113]), age (mean +/- SD, 43.3 +/- 16.1 years), female sex (n = 71), or presence of other heart or lung disease (n = 53). METHODS AND RESULTS: Transtelephonic monitoring of the ECG was used to document the rhythm during recurrences of symptomatic tachycardia. Time to first recurrence of symptomatic tachycardia and heart rate during tachycardia were measured, the observed rhythm was classified as irregular (consistent with paroxysmal atrial fibrillation) or regular (consistent with paroxysmal supraventricular tachycardia), and the hour of recurrence was recorded. Advancing age was significantly associated with a decreasing time to first recurrence (p < 0.001); the estimated increase in the hazard function was 25% with each 10 years of advancing age. After the effect of age was adjusted for, neither the classification of arrhythmia (p > 0.2), presence of other heart or lung disease (p > 0.8), nor sex (p > 0.9) was significantly associated with time to first recurrence. Among patients with paroxysmal supraventricular tachycardia, 6.5% had atrial fibrillation recorded at the next symptomatic arrhythmia; among patients with paroxysmal atrial fibrillation, 11.8% had a regular tachycardia recorded at the next symptomatic arrhythmia. There was a circadian pattern to the hour of occurrence of paroxysmal supraventricular tachycardia but not paroxysmal atrial fibrillation. CONCLUSIONS: Age is more important than other clinical variables, including the ECG classification of a paroxysmal supraventricular arrhythmia in predicting the occurrence of symptomatic arrhythmias. Arrhythmias documented by ECG during symptoms are often different from the arrhythmia documented at the time of referral, which may confound interpretation of antiarrhythmic drug effects.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Data from specialized centres on paroxysmal SVT patients referred for electrophysiology procedures indicate that patients tend to be younger, have similar age distribution, and lower prevalence of cardiovascular comorbidities.
“Data from specialized centres reporting on paroxysmal SVT patients referred for electrophysiology procedures, indicate that patients tend to be younger, have similar age distribution, and lower prevalence of cardiovascular comorbidities.5 -7”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 12 · Cited by 105
Research works printed but not linked: 9
- Irwin JM, McCarthy EA, Wilkinson WE, Pritchett ELC: Circadian occurrence of symptomatic paroxysmal supraventricular tachycar- dia in untreated patients. Circulation 1988;77:298-300
- Kalbfleish JD, Prentice RL: The Statistical Analysis ofFailure Time Data. New York, John Wiley & Sons, Inc, 1980
- Pritchett ELC, Smith MS, McCarthy EA, Kerry LL: The sponta- neous occurrence of paroxysmal supraventricular tachycardia. Cir- culation 1984;70:1-6
- Fleiss JL: Statistical Methods for Rates and Proportions. New York, John Wiley & Sons, Inc, 1981
- Yee R, Klein GJ, Sharma AD, Fujimura 0, Boahene KA: Tachy- cardia associated with accessory atrioventricular pathways, in Zipes DP, Jalife J (eds): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa, WB Saunders Co, 1990, pp 463-472
- Bauernfeind RA, Wyndham CR, Swiryn SP, Palileo EV, Strasberg B, Lam W, Westveer D, Rosen KM: Atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol 1981;47:562-569
- Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Bhandari AK, Hawkinson RW, Pritchett ELC, the Flecainide Supraventricular Tachycardia Study Group: Prevention of symp- tomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy: A multicenter, double- blind, placebo-controlled, crossover study of flecainide and pla- cebo using transtelephonic monitoring. Circulation 1989;80: 1557-1570
- Clair WK, Wilkinson WE, McCarthy EA, Pritchett ELC: Treat- ment of paroxysmal supraventricular tachycardia with oral diltia- zem. Clin Pharmacol Ther 1992;51:562-565
- Pritchett ELC, McCarthy EA, Wilkinson WE: Propafanone treat- ment of symptomatic paroxysmal supraventricular arrhythmias: A randomized, placebo-controlled, crossover trial in patients tolerat- ing oral therapy. Ann Intern Med 1991;114:539-544
- Authors
- Clair, W. K., Wilkinson, W. E., McCarthy, E. A., Page, R. L., & Pritchett, E. L.
- Affiliations
- Duke Medical Center (US)
- Venue
- Circulation
- Published
- 1993-04
- Volume
- 87
- Issue
- 4
- Pages
- 1114-1122
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2090345770
- Cited by
- 105
- References
- 12
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2022: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 5 · 2013: 3 · 2012: 6
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r01hl040392-01a1)
- National Heart, Lung, and Blood Institute (R01-HL-40392)
- National Center for Research Resources (MO 1 RR-30)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- paroxysmal supraventricular tachycardia, arrhythmia recurrence, untreated patients, age as risk factor, arrhythmia classification, sex differences, time to recurrence
- MeSH terms
- Adult, Age Factors, Atrial Fibrillation, Electrocardiography, Female, Humans, Male, Middle Aged, Recurrence, Tachycardia, Paroxysmal, Tachycardia, Supraventricular, Telephone, Time Factors, Wolff-Parkinson-White Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review